180
Views
4
CrossRef citations to date
0
Altmetric
Article

Longitudinal assessment of the platelet transcriptome in advanced heart failure patients following mechanical unloading

, , , , , , , & show all
Pages 952-959 | Received 10 Sep 2019, Accepted 07 Jan 2020, Published online: 14 Jan 2020

References

  • Kim JH, Shah P, Tantry US, Gurbel PA. Coagulation abnormalities in heart failure: pathophysiology and therapeutic implications. Curr Heart Fail Rep 2016;13:319–328. doi:10.1007/s11897-016-0308-6.
  • Koliopoulou A, McKellar SH, Rondina M, Selzman CH. Bleeding and thrombosis in chronic ventricular assist device therapy: focus on platelets. Curr Opin Cardiol 2016;31:299–307. doi:10.1097/HCO.0000000000000284.
  • Koupenova M, Clancy L, Corkrey HA, Freedman JE. Circulating platelets as mediators of immunity, inflammation, and thrombosis. Circ Res 2018;122:337–351. doi:10.1161/CIRCRESAHA.117.310795.
  • Rondina MT, Weyrich AS, Zimmerman GA. Platelets as cellular effectors of inflammation in vascular diseases. Circ Res 2013;112:1506–1519. doi:10.1161/CIRCRESAHA.113.300512.
  • Chung I, Lip GY. Platelets and heart failure. Eur Heart J 2006;27:2623–2631. doi:10.1093/eurheartj/ehl305.
  • Schafer A, Eigenthaler M, Bauersachs J. Platelet activation in heart failure. Clin Lab 2004;50:559–566.
  • Nascimbene A, Neelamegham S, Frazier OH, Moake JL, Dong JF. Acquired von Willebrand syndrome associated with left ventricular assist device. Blood 2016;127:3133–3141. doi:10.1182/blood-2015-10-636480.
  • Bartoli CR, Hennessy-Strahs S, Gohean J, Villeda M, Larson E, Longoria R, Kurusz M, Acker MA, Smalling R. A Novel toroidal-flow left ventricular assist device minimizes blood trauma: implications of improved ventricular assist device hemocompatibility. Ann Thorac Surg 2019;107:1761–1767. doi:10.1016/j.athoracsur.2018.11.053.
  • Campbell RA, Franks Z, Bhatnagar A, Rowley JW, Manne BK, Supiano MA, Schwertz H, Weyrich AS, Rondina MT. Granzyme A in human platelets regulates the synthesis of proinflammatory cytokines by monocytes in aging. J Immunol 2018;200:295–304. doi:10.4049/jimmunol.1700885.
  • Best MG, Vancura A, Wurdinger T. Platelet RNA as a circulating biomarker trove for cancer diagnostics. J Thromb Haemost 2017;15:1295–1306. doi:10.1111/jth.2017.15.issue-7.
  • Eicher JD, Wakabayashi Y, Vitseva O, Esa N, Yang Y, Zhu J, Freedman JE, McManus DD, Johnson AD. Characterization of the platelet transcriptome by RNA sequencing in patients with acute myocardial infarction. Platelets 2016;27:230–239. doi:10.3109/09537104.2015.1083543.
  • Rose JJ, Voora D, Cyr DD, Lucas JE, Zaas AK, Woods CW, Newby LK, Kraus WE, Ginsburg GS. Gene expression profiles link respiratory viral infection, platelet response to aspirin, and acute myocardial infarction. PLoS One 2015;10:e0132259. doi:10.1371/journal.pone.0132259.
  • Middleton EA, Rowley JW, Campbell RA, Grissom CK, Brown SM, Beesley SJ, Schwertz H, Kosaka Y, Manne BK, Krauel K, et al. Sepsis alters the transcriptional and translational landscape of human and murine platelets. Blood 2019;134:911–923. doi:10.1182/blood.2019000067.
  • Schwertz H, Rowley JW, Schumann GG, Thorack U, Campbell RA, Manne BK, Zimmerman GA, Weyrich AS, Rondina MT. Endogenous LINE-1 (Long interspersed nuclear element-1) reverse transcriptase activity in platelets controls translational events through RNA-DNA hybrids. Arterioscler Thromb Vasc Biol 2018;38:801–815. doi:10.1161/ATVBAHA.117.310552.
  • Schwertz H, Rowley JW, Zimmerman GA, Weyrich AS, Rondina MT. Retinoic acid receptor-alpha regulates synthetic events in human platelets. J Thromb Haemost 2017;15:2408–2418. doi:10.1111/jth.13861.
  • Campbell RA, Vieira-de-Abreu A, Rowley JW, Franks ZG, Manne BK, Rondina MT, Kraiss LW, Majersik JJ, Zimmerman GA, Weyrich AS. Clots are potent triggers of inflammatory cell gene expression: indications for timely fibrinolysis. Arterioscler Thromb Vasc Biol 2017;37:1819–1827. doi:10.1161/ATVBAHA.117.309794.
  • Rowley JW, Oler AJ, Tolley ND, Hunter BN, Low EN, Nix DA, Yost CC, Zimmerman GA, Weyrich AS. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 2011;118:e101–11. doi:10.1182/blood-2011-03-339705.
  • Madden JL, Drakos SG, Stehlik J, McKellar SH, Rondina MT, Weyrich AS, Selzman CH. Baseline red blood cell osmotic fragility does not predict the degree of post-LVAD hemolysis. Asaio J 2014;60:524–528. doi:10.1097/MAT.0000000000000106.
  • Shih L, Kaplan D, Kraiss LW, Casper TC, Pendleton RC, Peters CL, Supiano MA, Zimmerman GA, Weyrich AS, Rondina MT. Platelet-monocyte aggregates and C-reactive protein are associated with VTE in older surgical patients. Sci Rep 2016;6:27478. doi:10.1038/srep27478.
  • Rondina MT, Carlisle M, Fraughton T, Brown SM, Miller RR 3rd, Harris ES, Weyrich AS, Zimmerman GA, Supiano MA, Grissom CK. Platelet-monocyte aggregate formation and mortality risk in older patients with severe sepsis and septic shock. J Gerontol A Biol Sci Med Sci 2015;70:225–231. doi:10.1093/gerona/glu082.
  • Rondina MT, Brewster B, Grissom CK, Zimmerman GA, Kastendieck DH, Harris ES, Weyrich AS. In vivo platelet activation in critically ill patients with primary 2009 influenza A(H1N1). Chest 2012;141:1490–1495. doi:10.1378/chest.11-2860.
  • Burdess A, Michelsen AE, Brosstad F, Fox KA, Newby DE, Nimmo AF. Platelet activation in patients with peripheral vascular disease: reproducibility and comparability of platelet markers. Thromb Res 2012;129:50–55. doi:10.1016/j.thromres.2011.08.015.
  • Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001;104:1533–1537. doi:10.1161/hc3801.095588.
  • Pinney SP, Anyanwu AC, Lala A, Teuteberg JJ, Uriel N, Mehra MR. Left ventricular assist devices for lifelong support. J Am Coll Cardiol 2017;69:2845–2861. doi:10.1016/j.jacc.2017.04.031.
  • Koliopoulou A, Selzman CH. Stop the LVAD bleeding. J Thorac Dis 2017;9:E437–E439. doi:10.21037/jtd.
  • Shah P, Tantry US, Bliden KP, Gurbel PA. Bleeding and thrombosis associated with ventricular assist device therapy. J Heart Lung Transplant 2017;36:1164–1173. doi:10.1016/j.healun.2017.05.008.
  • Stehlik J, Johnson SA, Selzman CH. Gold standard in anticoagulation assessment of left ventricular assist device patients?: how about bronze. JACC Heart Fail 2015;3:323–326. doi:10.1016/j.jchf.2015.01.004.
  • Mehra MR, Goldstein DJ, Uriel N, Cleveland JC Jr., Yuzefpolskaya M, Salerno C, Walsh MN, Milano CA, Patel CB, Ewald GA, et al.; Investigators M. Two-year outcomes with a magnetically levitated cardiac pump in heart failure. N Engl J Med 2018;378:1386–1395. doi:10.1056/NEJMoa1800866.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.